Stock Detail
IMMUCOR INC
Diagnostic Substances
BLUD @ Yahoo Finance | BLUD Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $19.03 | $19.25 | $-0.11 | -0.57% | 0.00 | $19.14 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $19.20 | $18.98 | 191,802 | 1.33B | 427,128.67 | 16.02 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 19.36 | 19.20 | 19.09 | 18.93 | 18.82 |
Stock Profile
Immucor, Inc. engages in the development, manufacture, and marketing of immunological diagnostic medical products primarily in North America and Europe. It offers a line of reagents and automated systems that are used by hospitals, clinical laboratories, and blood banks in various tests performed to detect and identify various properties of cell and serum components of human blood. The company's reagent product lines include ABO blood grouping and Rh blood typing reagents, anti-human globulin serums, reagent red blood cells, rare serums, antibody potentiators, quality control systems, monoclonal antibody-based reagents, technical proficiency systems, and fetal bleed screen kit, as well as Capture-P, Capture-R, Capture-CMV, Capture-S, and Capture-R Select reagents. These reagents are used in tests performed prior to blood transfusion in determining the blood group and type of patients' and donors' blood; detection and identification of blood group antibodies; detection of platelet antibodies; and paternity testing. Immucor's blood bank automation products include ABS2000, an automated blood bank system; ROSYS Plato, a microplate liquid handler and sample processor; DIAS PLUS and GALILEO, which are high volume microplate processors; and Multireader Plus, a spectra photometric microtitration plate reader. These blood bank automation products enable technologist to perform blood compatibility tests. The company also distributes laboratory equipment designed to automate certain blood testing procedures. It sells its products through direct sales personnel, sales agents, and distributors worldwide. Immucor has a joint venture, known as Immucor-Kainos, Inc., with Kainos Laboratories, Inc. for the distribution of its products in Japan; and a development agreement with Inamed Corporation for the production of human collagen mesh. Immucor was founded in 1982 and is headquartered in Norcross, Georgia.